Advance Notice: EastPharma Ltd Sales Update Announcement for the period 30 September 2017
EASTPHARMA LTD.
London, 25 October 2017 - EastPharma (EAST LI) informs that it will be releasing its 9M 2017 sales performance and a review of its main subsidiary DEVA Holding's unaudited financial statements for the related period on 2 November 2017.
A conference call to review the 9M 2017 sales performance will be hosted by the management of EastPharma at 12:00-noon London time on
3 November 2017
(08:00am New York time / 01:00pm Zurich time / 03:00pm Istanbul time). The dial-in details are provided below.
Conference call:
Dial-in Number (UK): + 44 (0)20 7162 0077
Dial-in Number (US): + 1 646 851 2407
Dial-in Number (Switzerland): + 41 (0)434 5692 61
Dial-in Number (Germany): + 49 (0)695 8999 0507
Conference ID: 963050
For further information, please contact:
Investor Relations:
email:
ir@eastpharma.com
EastPharma Ltd
- a company active in the manufacturing and marketing of pharmaceutical products in Turkey and in other regional markets; for further information please visit
www.eastpharma.com
.
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: EastPharma Ltd via GlobeNewswire